EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Allosteric Control Overcomes Steric Limitations for Neutralizing Antibodies Targeting Conserved Binding Epitopes of the SARS-CoV-2 Spike Protein: Exploring the Intersection of Binding, Allostery, and Immune Escape with a Multimodal Computational Approach

Mohammed Alshahrani iD, Vedant Parikh iD, Brandon Foley, Gennady Verkhivker iD

Biomolecules · 2025

DOI: 10.3390/biom15091340 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomolecules, 2025. Verfasst von Mohammed Alshahrani und 3 weiteren Autor:innen. Beteiligte Einrichtung: Keck Center for Science and Engineering, Graduate Program in Computational and Data Sciences, Schmid College of Science and Technology, Chapman Unive…. Hauptthemen laut MEDLINE: Spike Glycoprotein, Coronavirus, Antibodies, Neutralizing, SARS-CoV-2, Epitopes. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 108 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Understanding the atomistic basis of multi-layer mechanisms employed by broadly reactive neutralizing antibodies of the SARS-CoV-2 spike protein without directly blocking receptor engagement remains an important challenge in coronavirus immunology. Class 4 antibodies represent an intriguing case: they target a deeply conserved, cryptic epitope on the receptor-binding domain yet exhibit variable neutralization potency across subgroups F1 (CR3022, EY6A, COVA1-16), F2 (DH1047), and F3 (S2X259). The molecular basis for this variability is not fully understood. Here, we employed a multi-modal computational approach integrating atomistic and coarse-grained molecular dynamics simulations, binding free energy calculations, mutational scanning, and dynamic network analysis to elucidate how these antibodies engage the receptor-binding domain (RBD) of the SARS-CoV-2 spike protein and influence its function. Our results reveal that neutralization efficacy arises from the interplay of direct interfacial interactions and allosteric effects. Group F1 antibodies (CR3022, EY6A, COVA1-16) primarily operate via classic allostery, modulating flexibility in RBD loop regions to indirectly interfere with the ACE2 receptor binding through long-range effects. Group F2 antibody DH1047 represents an intermediate mechanism, combining partial steric hindrance—through engagement of ACE2-critical residues T376, R408, V503, and Y508—with significant allosteric influence, facilitated by localized communication pathways linking the epitope to the receptor interface. Group F3 antibody S2X259 achieves potent neutralization through a synergistic mechanism involving direct competition with ACE2 and localized allosteric stabilization, albeit with potentially increased escape vulnerability. Dynamic network analysis identified a conserved “allosteric ring” within the RBD core that serves as a structural scaffold for long-range signal propagation, with antibody-specific extensions modulating communication to the ACE2 interface. These findings support a model where Class 4 neutralization strategies evolve through the refinement of peripheral allosteric connections rather than epitope redesign. This study establishes a robust computational framework for understanding the atomistic basis of neutralization activity and immune escape for Class 4 antibodies, highlighting how the interplay of binding energetics, conformational dynamics, and allosteric modulation governs their effectiveness against SARS-CoV-2.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Spike Glycoprotein, CoronavirusAntibodies, NeutralizingSARS-CoV-2EpitopesAntibodies, ViralHumansAllosteric RegulationMolecular Dynamics SimulationCOVID-19Protein BindingImmune EvasionAngiotensin-Converting Enzyme 2

Stichwörter der Autor:innen

Omicron variantsSARS-CoV-2 spike proteinantibody bindingbinding energeticsevolutionary mechanismsimmune escapemolecular dynamicsmutational scanningprotein stability

Substanzen

Spike Glycoprotein, Coronavirusspike protein, SARS-CoV-2Antibodies, NeutralizingEpitopesAntibodies, ViralAngiotensin-Converting Enzyme 2

Autor:innen und Institutionen

  • Keck Center for Science and Engineering, Graduate Program in Computational and Data Sciences, Schmid College of Science and Technology, Chapman University, Orange, CA 92866, USA.
  • Department of Biomedical and Pharmaceutical Sciences, Chapman University School of Pharmacy, Irvine, CA 92618, USA.

ORCID-Profile: Mohammed Alshahrani, Vedant Parikh, Gennady Verkhivker

Förderung

  • NIAID NIH HHS
  • NIH HHS
  • National Institutes of Health

Zitieren

APA

Alshahrani, M., Parikh, V., Foley, B., & Verkhivker, G. (2025). Allosteric Control Overcomes Steric Limitations for Neutralizing Antibodies Targeting Conserved Binding Epitopes of the SARS-CoV-2 Spike Protein: Exploring the Intersection of Binding, Allostery, and Immune Escape with a Multimodal Computational Approach. Biomolecules. https://doi.org/10.3390/biom15091340

Vancouver

Alshahrani M, Parikh V, Foley B, Verkhivker G. Allosteric Control Overcomes Steric Limitations for Neutralizing Antibodies Targeting Conserved Binding Epitopes of the SARS-CoV-2 Spike Protein: Exploring the Intersection of Binding, Allostery, and Immune Escape with a Multimodal Computational Approach. Biomolecules. 2025. doi:10.3390/biom15091340

BibTeX
@article{Alshahrani2025,
  author = {Alshahrani, Mohammed and Parikh, Vedant and Foley, Brandon and Verkhivker, Gennady},
  title = {Allosteric Control Overcomes Steric Limitations for Neutralizing Antibodies Targeting Conserved Binding Epitopes of the SARS-CoV-2 Spike Protein: Exploring the Intersection of Binding, Allostery, and Immune Escape with a Multimodal Computational Approach},
  journal = {Biomolecules},
  year = {2025},
  doi = {10.3390/biom15091340}
}
Kostenlos starten →